{"transactions":[{"id":685623,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-17T20:06:18.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":1797,"price":26.28,"value":47225.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on February 12, 2026. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.17 to $26.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 106,451 unvested RSUs."}],"balance_after":119766,"source":{"system":"sec-edgar","filing":"0001697616-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000169761626000002/ownership.xml","form_type":"4"}},{"id":725575,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T20:15:07.000Z","date":"2026-06-25","kind":"sale","planned":false,"acquired":false,"shares":2362,"price":20.37,"value":48113.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $20.33 to $20.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 110,513 unvested RSUs."}],"balance_after":121563,"source":{"system":"sec-edgar","filing":"0001193125-26-285505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000119312526285505/ownership.xml","form_type":"4"}},{"id":779359,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-14T20:03:26.000Z","date":"2026-05-13","kind":"sale","planned":true,"acquired":false,"shares":1448,"price":18.36,"value":26585.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on February 12, 2026. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $18.20 to $18.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 110,513 unvested RSUs."}],"balance_after":123925,"source":{"system":"sec-edgar","filing":"0001193125-26-223961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000119312526223961/ownership.xml","form_type":"4"}},{"id":816631,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:10:06.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":5727,"price":18.64,"value":106751.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on March 31, 2025. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $18.24 to $18.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 114,575 unvested RSUs."}],"balance_after":125373,"source":{"system":"sec-edgar","filing":"0001193125-26-142137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000119312526142137/ownership.xml","form_type":"4"}},{"id":901188,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-17T22:08:46.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 12, 2026. The shares underlying the option are scheduled to vest over four years in equal monthly installments through February 12, 2030."}],"balance_after":105000,"derivative":{"exercise_price":16,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001193125-26-055052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000119312526055052/ownership.xml","form_type":"4"}},{"id":901187,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:08:46.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of Common Stock issuable under 65,000 restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on May 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 131,100 unvested RSUs."}],"balance_after":131100,"source":{"system":"sec-edgar","filing":"0001193125-26-055052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000119312526055052/ownership.xml","form_type":"4"}},{"id":963750,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-12-18T21:50:03.000Z","date":"2025-12-16","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on December 16, 2026 and December 16, 2027."},{"field":"security","element":"securityTitle","label":"F2","text":"This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on December 16, 2026 and December 16, 2027."}],"balance_after":150000,"derivative":{"exercise_price":3.99,"expiration_date":"2035-12-16","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193125-25-324991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525324991/ownership.xml","form_type":"4"}},{"id":1005573,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":3750,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005572,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.892,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005571,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1250,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005570,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005569,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1000,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005568,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005567,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1250,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005566,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005565,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1250,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005564,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005563,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1500,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005562,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005561,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":2000,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005560,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005559,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":2250,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1005558,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:51:50.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001493152-25-021154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225021154/ownership.xml","form_type":"4"}},{"id":1186556,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-01T20:33:30.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":214500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on March 31, 2025. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on March 31, 2026, and the remainder vesting in 12 equal quarterly installments thereafter, subject to continuous service."}],"balance_after":214500,"derivative":{"exercise_price":10.46,"expiration_date":"2035-03-30","underlying":"Common Stock","underlying_shares":214500},"source":{"system":"sec-edgar","filing":"0000950170-25-048601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000095017025048601/ownership.xml","form_type":"4"}},{"id":1186555,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-01T20:33:30.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":66100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of Common Stock issuable under 66,100 restricted stock units (\"RSU\"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest as to 25% of the shares in equal annual installments over four years with the first installment vesting on March 31, 2026, subject to continuous service."}],"balance_after":66100,"source":{"system":"sec-edgar","filing":"0000950170-25-048601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000095017025048601/ownership.xml","form_type":"4"}},{"id":1188657,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-03-28T21:12:59.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2025, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":75000,"derivative":{"exercise_price":0.2946,"expiration_date":"2035-03-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001641172-25-001285","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000164117225001285/ownership.xml","form_type":"4"}},{"id":1189489,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:41:59.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026."}],"balance_after":70000,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001650664-25-000040","document":"wk-form4_1743108110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000040/wk-form4_1743108110.xml","form_type":"4"}},{"id":1189488,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:41:59.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":275100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029."}],"balance_after":275100,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":275100},"source":{"system":"sec-edgar","filing":"0001650664-25-000040","document":"wk-form4_1743108110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000040/wk-form4_1743108110.xml","form_type":"4"}},{"id":1221567,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T21:44:08.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":4109,"price":1.7108,"value":7029.6772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 12, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 3, 2025. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.7107 to $1.7150 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby\nundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":112720,"source":{"system":"sec-edgar","filing":"0001650664-25-000027","document":"wk-form4_1741211041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000027/wk-form4_1741211041.xml","form_type":"4"}},{"id":1350569,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350568,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.25,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350567,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350566,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.8,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350565,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350564,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.32,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350563,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350562,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.45,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350561,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350560,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.87,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350559,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350558,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.28,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350557,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1350556,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:54:07.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.53,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-047885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224047885/ownership.xml","form_type":"4"}},{"id":1432195,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-15T21:09:28.000Z","date":"2024-08-14","kind":"purchase","planned":false,"acquired":true,"shares":39266,"price":0.3964,"value":15565.0424,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.3827 to $0.3925, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":43608,"source":{"system":"sec-edgar","filing":"0001493152-24-032675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224032675/ownership.xml","form_type":"4"}},{"id":1453205,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-17T20:30:09.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026."}],"balance_after":20000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-07-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-084291","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024084291/ownership.xml","form_type":"4"}},{"id":1505050,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-22T20:30:13.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":22337,"price":5.6142,"value":125404.3854,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 12, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 17, 2024. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":116829,"source":{"system":"sec-edgar","filing":"0001650664-24-000044","document":"wk-form4_1716409797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000044/wk-form4_1716409797.xml","form_type":"4"}},{"id":1564530,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-22T01:01:02.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2024, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":45000,"derivative":{"exercise_price":1.53,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-010865","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224010865/ownership.xml","form_type":"4"}},{"id":1593960,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2024-03-06T01:06:54.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":106000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on  April 2, 2024 through March 2, 2028."}],"balance_after":106000,"derivative":{"exercise_price":10.53,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":106000},"source":{"system":"sec-edgar","filing":"0001650664-24-000019","document":"wk-form4_1709687193.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000019/wk-form4_1709687193.xml","form_type":"4"}},{"id":1593959,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T01:06:54.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":25966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition, upon the achievement of a specified business development milestone, of a portion of a performance-based restricted stock unit award originally granted on May 17, 2023. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on  May 17, 2024, subject to continued service."}],"balance_after":139166,"source":{"system":"sec-edgar","filing":"0001650664-24-000019","document":"wk-form4_1709687193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000019/wk-form4_1709687193.xml","form_type":"4"}},{"id":1593958,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T01:06:54.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":35300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2025 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2028."}],"balance_after":113200,"source":{"system":"sec-edgar","filing":"0001650664-24-000019","document":"wk-form4_1709687193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000019/wk-form4_1709687193.xml","form_type":"4"}},{"id":1776120,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-09-20T18:54:16.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":85763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":85763,"derivative":{"exercise_price":0.64,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":85763},"source":{"system":"sec-edgar","filing":"0001493152-23-033177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223033177/ownership.xml","form_type":"4"}},{"id":1886436,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-05-18T21:20:05.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":155800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 17, 2023 and is scheduled to vest over four years, with 25% of the shares to vest on May 17, 2024 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through May 17, 2027."}],"balance_after":155800,"derivative":{"exercise_price":9.61,"expiration_date":"2033-05-16","underlying":"Common Stock","underlying_shares":155800},"source":{"system":"sec-edgar","filing":"0001415889-23-008293","document":"form4-05182023_090554.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923008293/form4-05182023_090554.xml","form_type":"4"}},{"id":1886435,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2023-05-18T21:20:05.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":77900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting  Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on May 17, 2024 continuing through May 17, 2027."}],"balance_after":77900,"source":{"system":"sec-edgar","filing":"0001415889-23-008293","document":"form4-05182023_090554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923008293/form4-05182023_090554.xml","form_type":"4"}},{"id":1926053,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-05T21:01:45.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a three-year period, vesting 1/36 monthly beginning with the month following the Reporting Person's commencement of service as a director (April 3, 2023). This represents the initial grant to the Reporting Person as a member of the Board of Directors."}],"balance_after":25000,"derivative":{"exercise_price":0.465,"expiration_date":"2033-04-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-23-009554","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000143774923009554/rdgdoc.xml","form_type":"4"}},{"id":1933743,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T20:15:22.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2023, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":40000,"derivative":{"exercise_price":6.28,"expiration_date":"2033-03-28","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-010273","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315223010273/ownership.xml","form_type":"4"}},{"id":1944122,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-20T20:10:46.000Z","date":"2023-03-16","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.817,"value":13634.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.815 to $6.817, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":4342,"source":{"system":"sec-edgar","filing":"0001493152-23-008245","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315223008245/ownership.xml","form_type":"4"}},{"id":1963093,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-03-08T11:20:25.000Z","date":"2022-08-23","kind":"grant","acquired":true,"shares":36845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":68516,"derivative":{"exercise_price":1.61,"expiration_date":"2027-08-23","underlying":"Common Stock","underlying_shares":36845},"source":{"system":"sec-edgar","filing":"0001493152-23-006966","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223006966/ownership.xml","form_type":"4"}},{"id":2050648,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T17:11:41.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":218800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":218800},"source":{"system":"sec-edgar","filing":"0000899243-23-002182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924323002182/doc4.xml","form_type":"4"}},{"id":2050647,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T17:11:41.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":9.12,"expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-002182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924323002182/doc4.xml","form_type":"4"}},{"id":2050646,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T17:11:41.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":6.7,"expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-23-002182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924323002182/doc4.xml","form_type":"4"}},{"id":2347044,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T13:33:16.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2022, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":30000,"derivative":{"exercise_price":6.87,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-22-006149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315222006149/ownership.xml","form_type":"4"}},{"id":2368761,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-02-28T11:02:06.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":8722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":31671,"derivative":{"exercise_price":3.52,"expiration_date":"2032-01-01","underlying":"Common Stock","underlying_shares":8722},"source":{"system":"sec-edgar","filing":"0001493152-22-005543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005543/ownership.xml","form_type":"4"}},{"id":2368760,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-02-28T11:02:06.000Z","date":"2021-10-26","kind":"grant","acquired":true,"shares":2949,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22949,"derivative":{"exercise_price":5.25,"exercise_date":"2021-12-31","expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":2949},"source":{"system":"sec-edgar","filing":"0001493152-22-005543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005543/ownership.xml","form_type":"4"}},{"id":2388119,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-17T17:00:17.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":218800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal monthly installments from February 15, 2022 through February 15, 2026, subject to the Reporting Person's continued service to the Company."}],"balance_after":218800,"derivative":{"exercise_price":3.67,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":218800},"source":{"system":"sec-edgar","filing":"0001628280-22-003056","document":"wf-form4_164513518447933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000162828022003056/wf-form4_164513518447933.xml","form_type":"4"}},{"id":2746815,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-16T16:05:24.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal monthly installments from February 5, 2021 through February 5, 2025, subject to the Reporting Person's continued service to the Company."}],"balance_after":100000,"derivative":{"exercise_price":9.12,"expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-21-016104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924321016104/doc4.xml","form_type":"4"}},{"id":2802486,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-09T00:57:09.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2021, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":25000,"derivative":{"exercise_price":5.45,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-21-005623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315221005623/ownership.xml","form_type":"4"}},{"id":2811156,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tranche B Warrant (Right to Buy)","published_at":"2021-03-03T22:50:22.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":1171,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.25,"exercise_date":"2018-02-16","expiration_date":"2021-02-16","underlying":"Common Stock","underlying_shares":1171},"source":{"system":"sec-edgar","filing":"0001493152-21-005312","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315221005312/ownership.xml","form_type":"4"}},{"id":2811155,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T22:50:22.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":1171,"price":4.25,"value":4976.75,"ownership":{"direct":true},"balance_after":2342,"source":{"system":"sec-edgar","filing":"0001493152-21-005312","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315221005312/ownership.xml","form_type":"4"}},{"id":3315175,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-08T16:31:45.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest on January 6, 2021, and the remainder of this option shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Company."}],"balance_after":500000,"derivative":{"exercise_price":0.67,"expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-20-000827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924320000827/doc4.xml","form_type":"4"}},{"id":3603644,"issuer":{"id":152233,"kind":"organization","name":"Valeritas Holdings Inc.","symbol":"VLRX"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-08T16:56:30.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shall vest on March 07, 2020, the one-year anniversary of the date of grant. The remaining shares underlying the option vest in substantially equal quarterly installments for 8 quarters after such one-year anniversary, such that the option will fully vest on March 07, 2022."}],"balance_after":280000,"derivative":{"exercise_price":0.43,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001697616-19-000002","document":"wf-form4_155208217474070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619250/000169761619000002/wf-form4_155208217474070.xml","form_type":"4"}},{"id":3755982,"issuer":{"id":152233,"kind":"organization","name":"Valeritas Holdings Inc.","symbol":"VLRX"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-20T16:51:50.000Z","date":"2018-11-19","kind":"grant","acquired":true,"shares":363000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the option shall vest on November 19, 2019, the one-year anniversary of the date of grant. The remaining shares underlying the option vest in substantially equal quarterly installments for 4 quarters after such one-year anniversary, such that the option will fully vest on November 19, 2020."}],"balance_after":363000,"derivative":{"exercise_price":0.41,"expiration_date":"2028-11-19","underlying":"Common Stock","underlying_shares":363000},"source":{"system":"sec-edgar","filing":"0001697616-18-000005","document":"wf-form4_154275069279424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619250/000169761618000005/wf-form4_154275069279424.xml","form_type":"4"}},{"id":3842955,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-08-15T21:24:39.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options will vest as to 25% of the shares on December 31, 2018 and on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":25000,"derivative":{"exercise_price":4.25,"expiration_date":"2028-08-12","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-18-012104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315218012104/ownership.xml","form_type":"4"}},{"id":3953380,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tranche A Warrant (right to buy)","published_at":"2018-04-30T21:37:44.000Z","date":"2018-02-16","kind":"exercise","acquired":false,"shares":1171,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.25,"exercise_date":"2018-02-16","expiration_date":"2018-02-19","underlying":"Common stock","underlying_shares":1171},"source":{"system":"sec-edgar","filing":"0001178913-18-001369","document":"zk1821548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000117891318001369/zk1821548.xml","form_type":"4"}},{"id":3953379,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tranche B Warrant (right to buy)","published_at":"2018-04-30T21:37:44.000Z","date":"2018-02-16","kind":"purchase","acquired":true,"shares":1171,"price":0.01,"value":11.71,"ownership":{"direct":true},"balance_after":1171,"derivative":{"exercise_price":4.25,"exercise_date":"2018-02-16","expiration_date":"2021-02-15","underlying":"Common stock","underlying_shares":1171},"source":{"system":"sec-edgar","filing":"0001178913-18-001369","document":"zk1821548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000117891318001369/zk1821548.xml","form_type":"4"}},{"id":3953378,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tranche A Warrant (right to buy)","published_at":"2018-04-30T21:37:44.000Z","date":"2018-02-16","kind":"purchase","acquired":true,"shares":1171,"price":0.01,"value":11.71,"ownership":{"direct":true},"balance_after":1171,"derivative":{"exercise_price":4.25,"exercise_date":"2018-02-16","expiration_date":"2018-02-19","underlying":"Common stock","underlying_shares":1171},"source":{"system":"sec-edgar","filing":"0001178913-18-001369","document":"zk1821548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000117891318001369/zk1821548.xml","form_type":"4"}},{"id":3953377,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-30T21:37:44.000Z","date":"2018-02-16","kind":"exercise","acquired":true,"shares":1171,"price":4.25,"value":4976.75,"ownership":{"direct":true},"balance_after":1171,"source":{"system":"sec-edgar","filing":"0001178913-18-001369","document":"zk1821548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641631/000117891318001369/zk1821548.xml","form_type":"4"}},{"id":4054176,"issuer":{"id":152233,"kind":"organization","name":"Valeritas Holdings Inc.","symbol":"VLRX"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-15T16:41:48.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shall vest on February 13, 2019, the one-year anniversary of the date of grant. The remaining shares underlying the option vest in substantially equal quarterly installments for 8 quarters after such one-year anniversary."}],"balance_after":27000,"derivative":{"exercise_price":3.07,"expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001697616-18-000002","document":"wf-form4_151873089239649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619250/000169761618000002/wf-form4_151873089239649.xml","form_type":"4"}},{"id":4307663,"issuer":{"id":152233,"kind":"organization","name":"Valeritas Holdings Inc.","symbol":"VLRX"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-05-23T16:17:02.000Z","date":"2017-05-22","kind":"purchase","acquired":true,"shares":500,"price":4.95,"value":2475.0,"ownership":{"direct":true},"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001697616-17-000002","document":"wf-form4_149557060702939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619250/000169761617000002/wf-form4_149557060702939.xml","form_type":"4"}},{"id":4307662,"issuer":{"id":152233,"kind":"organization","name":"Valeritas Holdings Inc.","symbol":"VLRX"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-05-23T16:17:02.000Z","date":"2017-05-22","kind":"purchase","acquired":true,"shares":1000,"price":4.95,"value":4950.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001697616-17-000002","document":"wf-form4_149557060702939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619250/000169761617000002/wf-form4_149557060702939.xml","form_type":"4"}},{"id":4371263,"issuer":{"id":152233,"kind":"organization","name":"Valeritas Holdings Inc.","symbol":"VLRX"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-27T17:43:07.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":73800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shall vest on March 23, 2018, the one year anniversary of the date of grant.  The remaining shares underlying the option vest in substantially equal quarterly installments for 12 quarters after such six-month anniversary."}],"balance_after":73800,"derivative":{"exercise_price":7.12,"expiration_date":"2027-03-23","underlying":"Common Stock","underlying_shares":73800},"source":{"system":"sec-edgar","filing":"0000899243-17-008671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619250/000089924317008671/doc4.xml","form_type":"4"}},{"id":4371262,"issuer":{"id":152233,"kind":"organization","name":"Valeritas Holdings Inc.","symbol":"VLRX"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-27T17:43:07.000Z","date":"2017-03-23","kind":"purchase","acquired":true,"shares":3000,"price":10,"value":30000.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000899243-17-008671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619250/000089924317008671/doc4.xml","form_type":"4"}}]}